JOP20200318A1 - عوامل تثبيط ask1 - Google Patents

عوامل تثبيط ask1

Info

Publication number
JOP20200318A1
JOP20200318A1 JOP/2020/0318A JOP20200318A JOP20200318A1 JO P20200318 A1 JOP20200318 A1 JO P20200318A1 JO P20200318 A JOP20200318 A JO P20200318A JO P20200318 A1 JOP20200318 A1 JO P20200318A1
Authority
JO
Jordan
Prior art keywords
inhibiting agents
ask1
ask1 inhibiting
agents
available
Prior art date
Application number
JOP/2020/0318A
Other languages
English (en)
Inventor
Martin Himmelbauer
John H Jones
Michael Dechantsreiter
Zhili Xin
Lopez De Turiso Felix Gonzalez
Original Assignee
Biogen Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Ma Inc filed Critical Biogen Ma Inc
Publication of JOP20200318A1 publication Critical patent/JOP20200318A1/ar

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

غير متوفر
JOP/2020/0318A 2018-06-27 2019-06-26 عوامل تثبيط ask1 JOP20200318A1 (ar)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862690674P 2018-06-27 2018-06-27
PCT/US2019/039156 WO2020006031A1 (en) 2018-06-27 2019-06-26 Ask1 inhibiting agents

Publications (1)

Publication Number Publication Date
JOP20200318A1 true JOP20200318A1 (ar) 2020-12-10

Family

ID=67254023

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2020/0318A JOP20200318A1 (ar) 2018-06-27 2019-06-26 عوامل تثبيط ask1

Country Status (23)

Country Link
US (2) US11814362B2 (ar)
EP (1) EP3814333B1 (ar)
JP (1) JP2021528456A (ar)
KR (1) KR20210024532A (ar)
CN (1) CN112638896A (ar)
AR (1) AR115636A1 (ar)
AU (1) AU2019291806A1 (ar)
BR (1) BR112020026423A2 (ar)
CA (1) CA3104662A1 (ar)
CL (1) CL2020003375A1 (ar)
CO (1) CO2021000782A2 (ar)
CR (1) CR20210049A (ar)
EA (1) EA202190034A1 (ar)
ES (1) ES3032286T3 (ar)
IL (1) IL279709A (ar)
JO (1) JOP20200318A1 (ar)
MA (1) MA53009A (ar)
MX (1) MX2020013895A (ar)
PE (1) PE20211379A1 (ar)
SG (1) SG11202012784SA (ar)
TW (1) TW202035389A (ar)
UY (1) UY38278A (ar)
WO (1) WO2020006031A1 (ar)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112654621B (zh) 2018-06-27 2024-05-14 百时美施贵宝公司 可作为t细胞活化剂的经取代萘啶酮化合物
MX2020013895A (es) 2018-06-27 2021-07-21 Biogen Ma Inc Agentes inhibidores de ask1.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
TWI491606B (zh) * 2009-07-13 2015-07-11 Gilead Sciences Inc 調節細胞凋亡信號之激酶的抑制劑
UY35212A (es) * 2012-12-21 2014-06-30 Gilead Sciences Inc Inhibidores de la quinasa que regula la señal de la apoptosis
PE20160859A1 (es) * 2013-12-20 2016-09-18 Gilead Sciences Inc Inhibidores de la quinasa reguladora de la senal de apoptosis
WO2018151830A1 (en) 2017-02-17 2018-08-23 Fronthera U.S. Pharmaceuticals Llc Pyridinyl based apoptosis signal-regulation kinase inhibitors
MX2020013895A (es) 2018-06-27 2021-07-21 Biogen Ma Inc Agentes inhibidores de ask1.

Also Published As

Publication number Publication date
US20210115020A1 (en) 2021-04-22
IL279709A (en) 2021-03-01
US12404263B2 (en) 2025-09-02
CR20210049A (es) 2021-07-01
BR112020026423A2 (pt) 2021-03-23
EP3814333B1 (en) 2025-03-19
US20240109867A1 (en) 2024-04-04
MX2020013895A (es) 2021-07-21
CO2021000782A2 (es) 2021-01-29
TW202035389A (zh) 2020-10-01
EA202190034A1 (ru) 2021-04-08
WO2020006031A1 (en) 2020-01-02
AR115636A1 (es) 2021-02-10
KR20210024532A (ko) 2021-03-05
EP3814333A1 (en) 2021-05-05
WO2020006031A8 (en) 2020-09-24
AU2019291806A1 (en) 2021-01-07
SG11202012784SA (en) 2021-01-28
CL2020003375A1 (es) 2021-09-03
JP2021528456A (ja) 2021-10-21
UY38278A (es) 2020-01-31
ES3032286T3 (en) 2025-07-16
CA3104662A1 (en) 2020-01-02
US11814362B2 (en) 2023-11-14
CN112638896A (zh) 2021-04-09
PE20211379A1 (es) 2021-07-27
MA53009A (fr) 2021-05-05

Similar Documents

Publication Publication Date Title
CL2022000448A1 (es) Autoinyector (divisional solicitud no. 201903061)
JOP20200276A1 (ar) مثبطات أحادي أسيل جليسرول ليباز (magl)
GEP20227403B (en) Compounds
CL2020000595S1 (es) Estuche de auriculares.
CL2020000596S1 (es) Auriculares.
CL2019001554S1 (es) Automóvil.
CL2018000947S1 (es) Automóvil
CO2019003709A2 (es) Conjugados de pirrolobenzodiazepina
GEP20217234B (en) Pyridopyrimdinone cdk2/4/6 inhibitors
JOP20190267A1 (ar) مثبطات بيرازول magl
CL2018001940S1 (es) Automóvil
JOP20200300A1 (ar) أجسام مضادة لـ il-11ra
JOP20210036A1 (ar) مثبطات او- جليكوبروتين-2-أسيتاميدو-2-ديوكسي-3-دي-جلوكوبيرانوسيداز
CL2020000902A1 (es) Conexión flexible antisísmica
CL2018000791S1 (es) Automóvil
JOP20200318A1 (ar) عوامل تثبيط ask1
JOP20210025A1 (ar) تركيبات وطرق للتنشيط المتحكم فيه للمبيض
JOP20200034A1 (ar) تركيبة للتنشيط المتحكم فيه للمبيض
EP3773577A4 (en) TRICYCLIC ASK1 INHIBITORS
JOP20200056A1 (ar) تركيب غلاية
JOP20200108A1 (ar) توليفات شحمية
CL2019001123S1 (es) Cepillo de dientes.
CL2019001121S1 (es) Cepillo de dientes.
MA53225A (fr) Agents inhibiteurs d'ask1
CL2019001113S1 (es) Componente de retención.